Feasibility of recruitment to a randomised clinical trial for patients with heart failure and preserved ejection fraction and frailty

Back

HFA Premium Access

Feasibility of recruitment to a randomised clinical trial for patients with heart failure and preserved ejection fraction and frailty

Session: Interplay of frailty, sarcopenia, depression, and cardio-oncology in heart failure outcomes

Topic: Comorbidities

Speaker: Mr L. Eleyan (Leeds, GB)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Mr Loay Eleyan

Leeds Teaching Hospitals NHS Trust, Leeds (United Kingdom of Great Britain & Northern Ireland)

0 follower

6 more presentations in this session

Impact of sarcopenia and dynapenia on the prognosis of right heart failure

Speaker: Doctor C. Chavez Guzman (Mexico City, MX)

Frailty and bleeding events in patients with heart failure: Insights from the JROADHF-NEXT

Speaker: Doctor T. Nakade (Tokyo, JP)

The role of cystatin c-creatinine eGFR difference in assessing renal function and its correlation with frailty in patients with worsening heart failure: a real-world study

Speaker: Doctor C. Fumagalli (Varese, IT)

Specific antidepressant effects among heart failure patients with depression: real life data

Speaker: Professor M. Yilmaz (Izmir, TR)

The reverse cardio-oncology perspective: the incidence of, and mortality from, cancer subsequent to a diagnosis of heart failure; an updated review and meta-analysis of observational studies.

Speaker: Doctor L. Sanasi (Rome, IT)

Access the full session

Interplay of frailty, sarcopenia, depression, and cardio-oncology in heart failure outcomes

Speakers: Mr L. Eleyan, Doctor C. Chavez Guzman, Doctor T. Nakade, Doctor C. Fumagalli, Professor M. Yilmaz...

Access

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources